|Articles|May 5, 2015

Quintiles Opens Bioanalytical Lab in Europe

Author(s)News Update

May 5, 2015.

Quintiles has announced the expansion of its bioanalytical laboratory services with the establishment of a GLP-compliant bioanalytical liquid chromatography-mass spectrometry (LC-MS) laboratory. The laboratory, which is located in Oss, the Netherlands, will have extensive bioanalytical testing capabilities and will provide a European facility for customers to conduct pharmacokinetics studies.

Currently, Quintiles’ bioanalytical capabilities and work are managed out of three laboratory sites in the U.S. The new laboratory will be integrated with Quintiles’ existing laboratory in Ithaca, New York, enabling the transfer of assays back and forth to accommodate global studies. 


Related to this article

How QMM Can Help the C-Suite See a  $100 Million Problem Early
A passing FDA inspection tells pharma senior leadership very little about whether the next significant revenue vulnerability is already taking shape. But continuous, AI-enabled quality management maturity (QMM) has the potential to do so months before the issue reaches the realm of P&L.